Overview

Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study evaluated the safety and clinical effect of treatment with methylphenidate under different breakfast conditions (minimal breakfast versus standard continental breakfast) in children with Attention-Deficit Hyperactivity Disorder (ADHD).
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Methylphenidate